Download the full interview
One of the most revolutionary trends driving the biopharmaceutical sector is cell and gene therapy. According to the Journal of Gene Medicine, between 1989 and February 2016, over 2,300 clinical trials were conducted with more than half of them in phase one.
In a recent interview, Ger Brophy, Executive Vice President, Biopharma Production at Avantor, gave his perspective on this growing segment of the bioprocessing industry as he discussed several key trends and challenges. In his current role, Dr. Brophy is responsible for developing and implementing our Biopharma Production offering to support the current and future needs of our customers.
To download a copy of the complete interview, please fill out the following form.